Sfoglia per AUTORE
GUO Y
Collezione AOU Città della Salute di Torino
Items : 2
Osimertinib versus comparator first-generation epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in patients with advanced EGFR-mutated non-small cell lung cancer: a Chinese, multicenter, real-world cohort study. in Translational lung cancer research / Transl Lung Cancer Res. 2023 Nov 30;12(11):2229-2244. doi: 10.21037/tlcr-23-577. Epub 2023 Oct 26.
2023
AOU Città della Salute di Torino
AOU Città della Salute di Torino
Chen X; Zhang S; Gu Y; Tang Y; Mu X; Qin J; Yang X; He M; Liu Y; Zhong W; Gao J; Chen M; Zhao J; Gao X; Liu J; Zhang H; Shi Y; Zhao D; Shen F; Liu X; Zhang D; Pang L; Meng Q; Guo Y; Zhang Y; Li W; Xing P; Cheng Y; Xin T; et alii...
An atypical form of AOA2 with myoclonus associated with mutations in SETX and AFG3L2. in BMC medical genetics / BMC Med Genet. 2015 Mar 19;16:16. doi: 10.1186/s12881-015-0159-0.
2015
AOU Città della Salute di Torino
AOU Città della Salute di Torino
Mancini C; Orsi L; Guo Y; Li J; Chen Y; Wang F; Tian L; Liu X; Zhang J; Jiang H; Nmezi BS; Tatsuta T; Giorgio E; Di Gregorio E; Cavalieri S; Pozzi E; Mortara P; Caglio MM; Balducci A; Pinessi L; Langer T; Padiath QS; Hakonarson H; Zhang X; Brusco A;